Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Rheumatoid Arthritis: Time Is of the Essence

Sue Pondrom  |  Issue: June 2008  |  June 1, 2008

This is Part Two of a two-part series on early arthritis clinics. (See Part 1 on page 1 of the May 2008 issue.)

Over the last 20 years, early, aggressive treatment has become the standard of care for patients with rheumatoid arthritis (RA). Yet, there are relatively few specialized early arthritis clinics (EACs) available to the 1.3 million RA patients in the United States, in spite of the tremendous success of EACs in Europe. Why is this?

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

According to physicians interviewed by The Rheumatologist, there are many reasons for the paucity of this type of clinic:

  • America’s healthcare system differs from that of Europe—it’s not designed for early, easy patient access;
  • The referral base is not adequately educated about the nature of early inflammatory synovitis and the importance of early diagnosis and treatment;
  • Medical schools aren’t teaching new doctors enough about RA;
  • The effort needed to start an EAC does not appear to justify the time and expense; and
  • Many rheumatologists believe they can handle early RA patients within their existing schedules.

However, in spite of good intentions, most RA during the early stages of disease isn’t being seen in a timely manner.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Challenges for EACs in the U.S.

Ninety percent of patients with musculoskeletal and autoimmune disorders are receiving rheumatology care from their primary care physician (PCP), according to data gathered by Stephen A. Paget, MD, chair of the division of rheumatology at the Hospital for Special Surgery in New York City. In fact, less than 50% of RA patients are referred to specialists within the first six months of symptom onset.1 The actual percentage may be considerably lower, according to research by rheumatologist John J. Cush, MD, chief of rheumatology and clinical immunology at Presbyterian Hospital of Dallas. He that says fewer than 5% of RA patients are seen by rheumatologists in the first six months, and the average new RA patient comes in with disease duration of two to three years.

Is the solution to increasing access to establish an EAC? Not necessarily. It takes money to establish infrastructure, hire and train staff, and advertise to physicians and the public. Just because the EAC concept worked in Europe doesn’t mean it will in the U.S. For example, while Europe has an easier-to-negotiate single-payer insurance system, the U.S. has hundreds of payers, complicating the financial aspects. Also, European medical communities are relatively small, making it easier to educate and get referrals from local physicians. If an EAC is established in an American community, will the medical office get appropriate referrals?

Page: 1 2 3 4 | Single Page
Share: 

Filed under:ConditionsRheumatoid Arthritis Tagged with:clinicDiagnosisDiagnostic CriteriaRheumatoid arthritisTreatment

Related Articles

    Stop the Rheumatoid Arthritis (RA) Cascade Early

    May 1, 2008

    Early arthritis clinics pioneered diagnosis and treatment to prevent disease progression

    Key Studies Highlighted: 2 Industry Veterans Discuss Their Favorite Annual Meeting Abstracts

    March 19, 2020

    ATLANTA—With more than 3,000 abstracts from 103 countries presented at the 2019 ACR/ARP Annual Meeting in November, it was impossible for attendees to view them all. However, two ACR/ARP veterans—Arthur Kavanaugh, MD, from the University of California, San Diego, and John Cush, MD, from UT Southwestern Medical School, Dallas—chose to tackle the nearly impossible task and…

    Tips to Improve Communication with Colleagues & Patients

    October 31, 2019

    Crafting clear and captivating messaging for patients and colleagues isn’t always easy. Here are some tips to improve your approach…

    The Latest Autoinflammatory Discoveries & Tips

    March 17, 2018

    SAN DIEGO—Since the identification of the autoinflammatory disease, familial Mediter­ranean fever (FMF), researchers have identified an alphabet soup of other auto­inflammatory diseases with genetic underpinnings, from PAPA (pyogenic arthritis with pyoderma gangrenosum and acne) to NIAID (NLRP1-associated autoinflammation with arthritis and dyskeratosis) to TRAPS (TNF receptor-associated periodic syndrome). The torrent of discoveries, brought about largely…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences